Demant
ESRS disclosure: ESRS S4 \ DR S4-1 \ Paragraph AR 9
Tags Tree
- Can the company provide a detailed account of the process used to establish targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities, as outlined in Disclosure Requirement S4-5? This should include whether and how the company engaged directly with consumers, end-users, their legitimate representatives, or credible proxies with insight into their situation. Additionally, in accordance with Disclosure Requirement S4-1, the company is required to describe the key information necessary to ensure a faithful representation of the policies concerning consumers and end-users. This description must include explanations of any significant changes to the policies adopted during the reporting year, such as new expectations for business customers or new approaches to due diligence and remedy.
-
Question Id: S4-1_08
In 2024, Demant established new targets for advancing positive impacts on people with hearing loss: Improve more than 16 million lives by 2030, Increase awareness by performing hearing tests on more than 2 million people by 2030. The targets are set in relation to the overall ambition and purpose of Demant. The targets cover all markets where Demant is present. The target-setting process involved internal experts and was approved by Demant’s Executive Leadership Team and endorsed by the Board of Directors. Consumers and end-users were not directly involved in the process.
Report Date: 4Q2024Relevance: 60%
- Provide a detailed description of the processes your organization employs to identify necessary and appropriate actions in response to actual or potential material negative impacts on consumers and end-users. This should include the methodologies used to assess and manage these impacts, as well as the effectiveness of the actions taken.
-
Question Id: S4-4_05
Demant ensures compliance with regulations related to specific substances and defines quality management in policies for Hearing Aids and Diagnostics. They have established customer support service platforms for feedback and complaints, handled by a dedicated service team. Quality Management Systems demonstrate the ability to offer medical devices that meet customer needs and comply with regulatory requirements. Products are tested against reliability requirements, and extensive testing ensures safety and effectiveness throughout the product lifecycle.
Report Date: 4Q2024Relevance: 60%